WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Turning Point Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-04 09:24 am Purchase |
2021-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
WELLINGTON MANAGEMENT CO LLP | 4,009,654 8.100% |
4,009,654 (New Position) |
Filing |